Bixiye
QP90-21 Update for New to Market Medical Drugs: Tezepelumab, Faricimab, and Ranibizumab Injection (Susvimo implant)
Taariikhda uu dhaqangalayo Barnaamijka: Nov 10, 2021
Natiijooyinka Raadinta
Soo bandhiga 1991 - 2000 ee natiijooyinka 3688
Bixiye
Interleukin-1 (IL-1) Inhibitors - Medicaid
Prior Authorization, Quantity Limit
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2024
Bixiye
Interleukin-1 (IL-1) Inhibitors - Commercial
Prior Authorization, Quantity Limit
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2024
Bixiye
QP86-21 Commercial Pharmacy Benefit Exclusion for Mitigare®
Taariikhda uu dhaqangalayo Barnaamijka: Nov 10, 2021
Bixiye
QP87-21 Commercial Pharmacy Benefit Update – New and Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective January 1, 2022
Taariikhda uu dhaqangalayo Barnaamijka: Nov 10, 2021
Bixiye
P75-21 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Taariikhda uu dhaqangalayo Barnaamijka: Des 01, 2021
Bixiye
P76-21 New Medical, Medical Drug and Behavioral Health Policy Management Updates—Effective January 31, 2022
Taariikhda uu dhaqangalayo Barnaamijka: Des 01, 2021
Bixiye
P61R1-21 Update: Evaluation and Management Reimbursement Changes
Taariikhda uu dhaqangalayo Barnaamijka: Des 01, 2021